The largest database of trusted experimental protocols

Rcd4 cd3 cd4 cd69 cd25 hla dr t cells

Manufactured by STEMCELL

RCD4 (CD3+/CD4+/CD69-/CD25-/HLA-DR-) T cells are a population of T lymphocytes that express the CD3 and CD4 surface markers, but do not express CD69, CD25, or HLA-DR markers. These cells represent a specific subset of T helper cells.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using rcd4 cd3 cd4 cd69 cd25 hla dr t cells

1

Quantifying HIV-1 Replication Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
HIV-1 p24 protein production (replication-competent virus as measure of infectious particles production) was analyzed in quantitative viral outgrowth assays (QVOA) (19 (link), 29 (link)) after rCD4 T cells’ ex vivo exposure to N-BPs PAM and Zol. Briefly, magnetically isolated rCD4 (CD3+/CD4+/CD69-/CD25-/HLA-DR-) T cells (Stemcell Technologies) were rested in the presence of antiretroviral drugs (10nM Raltegravir and 20nM Efavirenz). Cells were washed, counted and plated in limiting dilution from 1x106 to 0.1x106 cells. Cells were treated with 5U/mL IL-2 as the negative control or exposed 24 hours to PHA and IL-2, or to N-BPs PAM, Zol and ALN. After washing, isolated PHA-activated CD4 cells from uninfected individuals were added twice during the 19-day culture as targets of new infections to outgrowth the virus. After 15 days of culture, supernatants were harvested and HIV-1p24 ELISA performed and confirmed at day 19 of culture. The frequency of infection was calculated and expressed as infectious units per million (IUPM) cultured cells, as explained in Statistical Methods.
+ Open protocol
+ Expand
2

Quantitative Viral Outgrowth Assay for HIV-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
HIV-1 p24 protein production (replication-competent virus as measure of infectious particles production) was analyzed in quantitative viral outgrowth assays (QVOA) (19 (link), 41 (link)) after rCD4 T cells’ ex vivo exposure to N-BPs PAM and Zol. Briefly, magnetically isolated rCD4 (CD3+/CD4+/CD69−/ CD25−/ HLA−DR−) T cells (Stemcell Technologies) were rested in the presence of antiretroviral drugs (10nM Raltegravir and 20nM Efavirenz). Cells were washed, counted and plated in limiting dilution from 1×106 to 0.1×106 cells. Cells were left untreated or exposed 24 hours to PHA and IL-2, or to N-BPs PAM, Zol and ALN. After washing, isolated PHA-activated CD4 cells from uninfected individuals were added twice during the 19-day culture as targets of new infections to outgrowth the virus. After 15 days of culture, supernatants were harvested and HIV-1p24 ELISA performed and confirmed at day 19 of culture. The frequency of infection was calculated and expressed as infectious units per million (IUPM) cultured cells, as explained in Statistical Methods.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!